https://www.selleckchem.com/pr....oducts/Gefitinib.htm
However, improvement of techniques, drugs and devices benefited to both men and women and tend to decrease gender gap. Especially, changes in the design of newer generation DES may be particularly important for women. Female sex remains a potent predictor of higher risk of bleeding and vascular complication; thus important efforts should be promoted to develop bleeding avoidance strategies. CONCLUSIONS Sex-based differences still deserve dedicated investigations in terms of physiopathology, particular hormonal impacts, and specific re
Like
Comment
Share
